Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
about
Bivalirudin versus Heparin plus Glycoprotein IIb/IIIa Inhibitors in Women Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.Efficacy and safety of bivalirudin versus heparin in patients with diabetes mellitus undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.Enhancing the Benefit of Bivalirudin in Percutaneous Coronary Intervention: Is High Risk of Bleeding the Key?
P2860
Bivalirudin Versus Heparin Plus Glycoprotein IIb/IIIa Inhibitors in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bivalirudin Versus Heparin Plu ...... Randomized Controlled Trials.
@en
type
label
Bivalirudin Versus Heparin Plu ...... Randomized Controlled Trials.
@en
prefLabel
Bivalirudin Versus Heparin Plu ...... Randomized Controlled Trials.
@en
P2093
P2860
P1476
Bivalirudin Versus Heparin Plu ...... Randomized Controlled Trials.
@en
P2093
Blake G Smith
Guy L Reed
Oluwaseyi Bolorunduro
Saibal Kar
Sam Dagogo-Jack
Smith Giri
Uzoma N Ibebuogu
P2860
P2888
P304
P356
10.1007/S40256-015-0113-8
P577
2015-08-01T00:00:00Z
P6179
1026377582